Oxybutynin Hydrochloride Aspire (Oxybutynin Hydrochloride)

Oxybutynin Hydrochloride is used within the urinary bladder therapeutic class:

• Overactive bladder: Reduces urinary urgency, frequency and urge incontinence.
• Detrusor overactivity: Relaxes the bladder muscle to improve storage capacity.
• Neurogenic bladder dysfunction: Helps control involuntary bladder contractions.

• Oxybutynin hydrochloride blocks muscarinic M3 receptors in the detrusor muscle of the bladder, decreasing involuntary contractions. This anticholinergic action reduces bladder pressure and increases functional capacity, allowing more controlled urine storage and thereby alleviating symptoms of overactive bladder.

Oxybutynin Hydrochloride may cause a range of adverse reactions.

Common Side Effects

• Dry mouth: Reduced salivary flow leading to a feeling of thirst.
• Constipation: Slowed gastrointestinal motility.
• Blurred vision: Transient visual disturbances.
• Drowsiness: Mild sedation or fatigue.
• Urinary retention: Difficulty initiating urination.

Serious or Rare Side Effects

• Tachycardia: Elevated heart rate that may require monitoring.
• Severe allergic reaction: Rash, itching, swelling, or difficulty breathing.
• Angle‑closure glaucoma: Sudden eye pain and visual loss.
• Hepatic dysfunction: Elevated liver enzymes or jaundice.
• Seizures: Uncommon but serious neurologic events.

When prescribing Oxybutynin Hydrochloride, consider the following safety measures:

• Assess renal function: Adjust dosage in patients with renal impairment.
• Review cardiovascular :  
• Evaluate  
• Monitor  
• Store at ambient : keep 

- - - -  -  -  -  -  -  -  -  -  -  -  -  -  -  - ",